Physician profile
Amit Shah
NPI 1225062128
$10,126.28
in general payments reported to CMS, 2019-2025
12 companies · $225 in 2025
The $225 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $574 · 2020: $696 · 2021: $1,662 · 2022: $5,270 · 2023: $849 · 2024: $850 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,155 · Travel and Lodging: $769.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,155.26 |
| Travel and Lodging | $768.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $8,055.58 | 2019-2025 | Aveir, Tacticath Ablation Catheter, Sensor Enabled, Agilis Hispro |
| Medtronic Vascular, INC. | $582.03 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $508.58 | 2020-2024 | Lifevest |
| Novartis Pharmaceuticals Corporation | $280.93 | 2019-2023 | |
| Cardiva Medical, INC. | $227.55 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Medtronic, INC. | $211.57 | 2021-2024 | Pulseselect, Flexcath Advance |
| Astrazeneca Pharmaceuticals LP | $99.00 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $55.26 | 2019-2023 | Camzyos |
| Janssen Pharmaceuticals, INC | $44.75 | 2020 | |
| Boston Scientific Corporation | $26.63 | 2023 | Emblem Mri S-Icd |
| Zimvie INC. | $21.87 | 2023 | |
| Pfizer INC. | $12.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.